Septerna stood out from the crowd of biotech IPOs last year due to the lack of clinical data to hand. Now, the data are ...

Bilirubin is a viscous, brownish-yellow substance that is a natural byproduct of liver processes like breaking down old red blood cells. Normally, it is excreted from the body without cause for ...

A gastroenterologist has revealed a number of changes to your skin that could indicate underlying liver disease. Dr Saurabh ...

Trial decision follows unanticipated events of elevated unconjugated bilirubin levelsCompany advancing multiple next-generation PTH1R agonists ...

Bilirubin is a resulting compound of the process of red blood cell breakdown. When bilirubin is broken down by the liver, it produces a compound called urobilin with a potent yellow pigment.

A bilirubin analyser is a device used to measure bilirubin levels and is often used in neonatal intensive units to screen new-borns for jaundice. The analysers either detect bilirubin levels in ...

Gallbladder problems are a common complication in individuals with sickle cell disease. These issues often arise due to the breakdown of red blood cells and the subsequent formation of gallstones or ...

In a clinical report issued by the American Academy of Pediatrics and published online Feb. 18 in Pediatrics, recommendations ...

Expert Rev of Obstet Gynecol. 2012;7(3):269-279. In summary, excess levels of urobilinogen and bilirubin in the urine may signal liver disease, and more research is needed to correlate these ...

Septerna (SEPN) announced its decision to discontinue the Phase 1 single- and multiple-ascending dose clinical trial of SEP-786 in healthy ...

Septerna discontinues phase 1 clinical trial of SEP-786; plans to advance next-generation oral small molecule PTH1R agonist: South San Francisco, California Friday, February 21, 2 ...